A detailed history of Nisa Investment Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 12,485 shares of BMRN stock, worth $1.01 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
12,485
Previous 13,015 4.07%
Holding current value
$1.01 Million
Previous $1.25 Million 13.08%
% of portfolio
0.01%
Previous 0.01%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 01, 2024

SELL
$83.81 - $99.0 $44,419 - $52,470
-530 Reduced 4.07%
12,485 $1.09 Million
Q4 2023

Jan 25, 2024

SELL
$76.22 - $98.51 $30,488 - $39,404
-400 Reduced 2.98%
13,015 $1.25 Million
Q3 2023

Nov 02, 2023

SELL
$85.07 - $94.48 $187,153 - $207,856
-2,200 Reduced 14.09%
13,415 $1.19 Million
Q1 2023

May 02, 2023

SELL
$87.74 - $117.27 $328,674 - $439,293
-3,746 Reduced 19.35%
15,615 $1.52 Million
Q4 2022

Feb 02, 2023

SELL
$80.93 - $108.63 $309,961 - $416,052
-3,830 Reduced 16.52%
19,361 $2 Million
Q3 2022

Nov 07, 2022

BUY
$82.16 - $96.94 $101,303 - $119,527
1,233 Added 5.62%
23,191 $1.97 Million
Q2 2022

Aug 03, 2022

SELL
$71.48 - $86.85 $262,974 - $319,521
-3,679 Reduced 14.35%
21,958 $1.82 Million
Q1 2022

Apr 29, 2022

BUY
$74.28 - $92.69 $703,060 - $877,310
9,465 Added 58.53%
25,637 $1.98 Million
Q4 2021

Feb 03, 2022

SELL
$71.72 - $91.47 $325,967 - $415,731
-4,545 Reduced 21.94%
16,172 $1.43 Million
Q3 2021

Oct 18, 2021

SELL
$74.77 - $85.47 $15,926 - $18,205
-213 Reduced 1.02%
20,717 $1.6 Million
Q2 2021

Aug 06, 2021

BUY
$75.51 - $84.79 $22,653 - $25,437
300 Added 1.45%
20,930 $1.75 Million
Q1 2021

Apr 26, 2021

BUY
$74.73 - $90.69 $22,419 - $27,207
300 Added 1.48%
20,630 $1.56 Million
Q4 2020

Jan 25, 2021

SELL
$72.61 - $90.2 $271,488 - $337,257
-3,739 Reduced 15.53%
20,330 $1.78 Million
Q3 2020

Oct 20, 2020

SELL
$71.87 - $131.03 $1.08 Million - $1.96 Million
-14,971 Reduced 38.35%
24,069 $1.83 Million
Q2 2020

Jul 27, 2020

BUY
$79.55 - $124.22 $439,991 - $687,060
5,531 Added 16.51%
39,040 $4.82 Million
Q1 2020

Apr 17, 2020

BUY
$71.37 - $96.85 $342,576 - $464,880
4,800 Added 16.72%
33,509 $2.83 Million
Q4 2019

Jan 17, 2020

BUY
$64.27 - $86.37 $159,003 - $213,679
2,474 Added 9.43%
28,709 $2.43 Million
Q3 2019

Oct 17, 2019

SELL
$67.4 - $85.11 $274,183 - $346,227
-4,068 Reduced 13.42%
26,235 $1.77 Million
Q2 2019

Jul 12, 2019

SELL
$80.35 - $93.9 $343,094 - $400,953
-4,270 Reduced 12.35%
30,303 $2.6 Million
Q1 2019

Apr 17, 2019

SELL
$84.2 - $98.62 $38,647 - $45,266
-459 Reduced 1.31%
34,573 $3.07 Million
Q4 2018

Jan 17, 2019

SELL
$80.14 - $106.07 $88,154 - $116,676
-1,100 Reduced 3.04%
35,032 $2.98 Million
Q3 2018

Oct 16, 2018

BUY
$93.92 - $105.72 $1.65 Million - $1.86 Million
17,612 Added 95.1%
36,132 $3.5 Million
Q2 2018

Jul 19, 2018

BUY
$76.01 - $99.03 $532,070 - $693,210
7,000 Added 60.76%
18,520 $1.75 Million
Q1 2018

Apr 10, 2018

BUY
$77.67 - $92.63 $58,252 - $69,472
750 Added 6.96%
11,520 $934,000
Q4 2017

Jan 12, 2018

SELL
$80.76 - $95.13 $4,038 - $4,756
-50 Reduced 0.46%
10,770 $960,000
Q3 2017

Oct 13, 2017

BUY
$80.6 - $94.95 $872,091 - $1.03 Million
10,820
10,820 $1.01 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.